The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi’s sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein

PLoS Pathogens

Volumn 14, Issue 3, 2018, Pages

  Bussey, Kendra A ^a   Lau, Ulrike ^a   Schumann, Sophie ^b   Gallo, Antonio ^c   Osbelt, Lisa ^a   Stempel, Markus ^a   Arnold, Christine ^a   Wissing, Josef ^a   Gad, Hans Henrik ^d   Hartmann, Rune ^d   Brune, Wolfram ^c   Jänsch, Lothar ^a   Whitehouse, Adrian ^b   Brinkmann, Melanie M ^a,e  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^d AARHUS UNIVERSITY   (Denmark)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLARIN; LIPOFECTAMINE; OLIGOADENYLATE SYNTHETASE LIKE PROTEIN; PUROMYCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRAL PROTEIN; 2',5' OLIGOADENYLATE SYNTHETASE; INTERFERON; RIBOSOME PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BACULOVIRIDAE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MASS SPECTROMETRY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; RADIOIMMUNOPRECIPITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS REPLICATION; AMINO ACID SEQUENCE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HERPES VIRUS INFECTION; METABOLISM; PATHOGENICITY; VIROLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; AMINO ACID SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INTERFERONS; OPEN READING FRAMES; RIBOSOMAL PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85044832564     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006937     Document Type: Article

References (58)

1. Davison AJ, Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Overview of classification. In: et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge2007.
2. Sunil M, Reid E, Lechowicz MJ, Update on HHV-8-Associated Malignancies. Curr Infect Dis Rep. 2010;12(2):147–54. doi: 10.1007/s11908-010-0092-5 20461118; PubMed Central PMCID: PMCPMC2860558.
3. Chen YB, Rahemtullah A, Hochberg E, Primary effusion lymphoma. Oncologist. 2007;12(5):569–76. doi: 10.1634/theoncologist.12-5-569 17522245.
4. Damania B, Cesarman E, Knipe DM, Howley PM, Kaposi's Sarcoma-Associated Herpesvirus. In: Fields Virology. 2. 6th ed.Philadelphia: Wolters Kluwer; 2013. p. 2080–128.
5. Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, et al. KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 2014;10(1):e1003847. doi: 10.1371/journal.ppat.1003847 24453964; PubMed Central PMCID: PMCPMC3894221.
6. Nascimento R, Dias JD, Parkhouse RM, The conserved UL24 family of human alpha, beta and gamma herpesviruses induces cell cycle arrest and inactivation of the cyclinB/cdc2 complex. Arch Virol. 2009;154(7):1143–9. doi: 10.1007/s00705-009-0420-y 19526192.
7. Nascimento R, Parkhouse RM, Murine gammaherpesvirus 68 ORF20 induces cell-cycle arrest in G2 by inhibiting the Cdc2-cyclin B complex. J Gen Virol. 2007;88(Pt 5):1446–53. doi: 10.1099/vir.0.82589-0 17412972.
8. Nascimento R, Costa H, Dias JD, Parkhouse RM, MHV-68 Open Reading Frame 20 is a nonessential gene delaying lung viral clearance. Arch Virol. 2011;156(3):375–86. doi: 10.1007/s00705-010-0862-2 21104281.
9. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L, Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog. 2008;4(7):e1000100. doi: 10.1371/journal.ppat.1000100 18617993; PubMed Central PMCID: PMCPMC2438612.
10. Sander G, Konrad A, Thurau M, Wies E, Leubert R, Kremmer E, et al. Intracellular localization map of human herpesvirus 8 proteins. J Virol. 2008;82(4):1908–22. doi: 10.1128/JVI.01716-07 18077714; PubMed Central PMCID: PMCPMC2258699.
11. Yoo SM, Zhou FC, Ye FC, Pan HY, Gao SJ, Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology. 2005;343(1):47–64. doi: 10.1016/j.virol.2005.08.018 16154170; PubMed Central PMCID: PMCPMC2814456.
12. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001;69(6):912–20. 11404376.
13. Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR, et al. Differential regulation of the OASL and OAS1 genes in response to viral infections. J Interferon Cytokine Res. 2009;29(4):199–207. doi: 10.1089/jir.2008.0050 19203244.
14. Rebouillat D, Marie I, Hovanessian AG, Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2'-5' oligoadenylate synthetase. Eur J Biochem. 1998;257(2):319–30. 9826176.
15. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–5. doi: 10.1038/nature09907 21478870; PubMed Central PMCID: PMCPMC3409588.
16. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 2014;505(7485):691–5. doi: 10.1038/nature12862 24284630; PubMed Central PMCID: PMCPMC4077721.
17. Marques J, Anwar J, Eskildsen-Larsen S, Rebouillat D, Paludan SR, Sen G, et al. The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain. J Gen Virol. 2008;89(Pt 11):2767–72. doi: 10.1099/vir.0.2008/003558-0 18931074.
18. Zhu J, Zhang Y, Ghosh A, Cuevas RA, Forero A, Dhar J, et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity. 2014;40(6):936–48. doi: 10.1016/j.immuni.2014.05.007 24931123; PubMed Central PMCID: PMCPMC4101812.
19. Hornung V, Hartmann R, Ablasser A, Hopfner KP, OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat Rev Immunol. 2014;14(8):521–8. doi: 10.1038/nri3719 25033909.
20. Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J, p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Res. 1998;26(18):4121–8. 9722630; PubMed Central PMCID: PMCPMC147837.
21. Ibsen MS, Gad HH, Andersen LL, Hornung V, Julkunen I, Sarkar SN, et al. Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling. Nucleic Acids Res. 2015;43(10):5236–48. doi: 10.1093/nar/gkv389 25925578; PubMed Central PMCID: PMCPMC4446440.
22. Eskildsen S, Justesen J, Schierup MH, Hartmann R, Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res. 2003;31(12):3166–73. 12799444; PubMed Central PMCID: PMCPMC162331.
23. Lee MS, Kim B, Oh GT, Kim YJ, OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol. 2013;14(4):346–55. doi: 10.1038/ni.2535 23416614.
24. Andersen JB, Strandbygard DJ, Hartmann R, Justesen J, Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1. Eur J Biochem. 2004;271(3):628–36. 14728690.
25. Mann M, Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol. 2006;7(12):952–8. doi: 10.1038/nrm2067 17139335.
26. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376–86. 12118079.
27. Doudna JA, Rath VL, Structure and function of the eukaryotic ribosome: the next frontier. Cell. 2002;109(2):153–6. 12007402.
28. Warner JR, Rich A, Hall CE, Electron Microscope Studies of Ribosomal Clusters Synthesizing Hemoglobin. Science. 1962;138(3548):1399–403. doi: 10.1126/science.138.3548.1399 17753859.
29. Abere B, Mamo TM, Hartmann S, Samarina N, Hage E, Ruckert J, et al. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. PLoS Pathog. 2017;13(9):e1006639. doi: 10.1371/journal.ppat.1006639 28938025; PubMed Central PMCID: PMCPMC5627962.
30. Lipps C, Badar M, Butueva M, Dubich T, Singh VV, Rau S, et al. Proliferation status defines functional properties of endothelial cells. Cell Mol Life Sci. 2017;74(7):1319–33. doi: 10.1007/s00018-016-2417-5 27853834.
31. May T, Butueva M, Bantner S, Markusic D, Seppen J, MacLeod RA, et al. Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A. 2010;16(2):441–52. doi: 10.1089/ten.TEA.2009.0184 19705962.
32. Vieira J, O'Hearn PM, Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology. 2004;325(2):225–40. doi: 10.1016/j.virol.2004.03.049 15246263.
33. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol. 2007;81(11):5995–6006. doi: 10.1128/JVI.01714-06 17376915; PubMed Central PMCID: PMCPMC1900311.
34. Schmidt EK, Clavarino G, Ceppi M, Pierre P, SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods. 2009;6(4):275–7. doi: 10.1038/nmeth.1314 19305406.
35. Jacobs SR, Gregory SM, West JA, Wollish AC, Bennett CL, Blackbourn DJ, et al. The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3. J Virol. 2013;87(2):798–806. doi: 10.1128/JVI.01851-12 23115281; PubMed Central PMCID: PMCPMC3554052.
36. Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, et al. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. J Virol. 2014;88(16):9245–59. doi: 10.1128/JVI.00841-14 24899179; PubMed Central PMCID: PMCPMC4136288.
37. Gallo A, Lampe M, Gunther T, Brune W, The Viral Bcl-2 Homologs of Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Rhadinovirus Share an Essential Role for Viral Replication. J Virol. 2017;91(6). doi: 10.1128/JVI.01875-16 28053098; PubMed Central PMCID: PMCPMC5331788.
38. Alkharsah KR, Singh VV, Bosco R, Santag S, Grundhoff A, Konrad A, et al. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J Virol. 2011;85(19):10375–88. doi: 10.1128/JVI.00226-11 21795355; PubMed Central PMCID: PMCPMC3196410.
39. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU, Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol. 2003;77(7):4205–20. doi: 10.1128/JVI.77.7.4205-4220.2003 12634378; PubMed Central PMCID: PMCPMC150665.
40. Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, et al. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol. 2001;75(10):4843–53. doi: 10.1128/JVI.75.10.4843-4853.2001 11312356; PubMed Central PMCID: PMCPMC114239.
41. Davis ZH, Verschueren E, Jang GM, Kleffman K, Johnson JR, Park J, et al. Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes. Mol Cell. 2015;57(2):349–60. doi: 10.1016/j.molcel.2014.11.026 25544563; PubMed Central PMCID: PMCPMC4305015.
42. Hoshino A, Fujii H, Redundant promoter elements mediate IL-3-induced expression of a novel cytokine-inducible gene, cyclon. FEBS Lett. 2007;581(5):975–80. doi: 10.1016/j.febslet.2007.01.083 17300783; PubMed Central PMCID: PMCPMC1839886.
43. Saint Fleur S, Hoshino A, Kondo K, Egawa T, Fujii H, Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon. Blood. 2009;114(7):1355–65. doi: 10.1182/blood-2008-11-189118 19528538; PubMed Central PMCID: PMCPMC2727414.
44. Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017;356(6340). doi: 10.1126/science.aal3321 28495876.
45. Mellacheruvu D, Wright Z, Couzens AL, Lambert JP, St-Denis NA, Li T, et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods. 2013;10(8):730–6. doi: 10.1038/nmeth.2557 23921808; PubMed Central PMCID: PMCPMC3773500.
46. Shi Z, Fujii K, Kovary KM, Genuth NR, Rost HL, Teruel MN, et al. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide. Mol Cell. 2017;67(1):71–83 e7. doi: 10.1016/j.molcel.2017.05.021 28625553; PubMed Central PMCID: PMCPMC5548184.
47. Dinman JD, Pathways to Specialized Ribosomes: The Brussels Lecture. J Mol Biol. 2016;428(10 Pt B):2186–94. doi: 10.1016/j.jmb.2015.12.021 26764228; PubMed Central PMCID: PMCPMC4884523.
48. Lipps C, Badar M, Butueva M, Dubich T, Singh VV, Rau S, et al. Proliferation status defines functional properties of endothelial cells. Cellular and Molecular Life Sciences. 2017;74(7):1319–33. doi: 10.1007/s00018-016-2417-5 27853834
49. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, et al. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest. 2010;120(9):3191–208. doi: 10.1172/JCI42955 20679731; PubMed Central PMCID: PMCPMC2929729.
50. Tischer BK, Smith GA, Osterrieder N, En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol. 2010;634:421–30. doi: 10.1007/978-1-60761-652-8_30 20677001.
51. Adler H, Messerle M, Wagner M, Koszinowski UH, Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol. 2000;74(15):6964–74. 10888635; PubMed Central PMCID: PMCPMC112213.
52. Boritz E, Gerlach J, Johnson JE, Rose JK, Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol. 1999;73(8):6937–45. 10400792; PubMed Central PMCID: PMCPMC112779.
53. David A, Dolan BP, Hickman HD, Knowlton JJ, Clavarino G, Pierre P, et al. Nuclear translation visualized by ribosome-bound nascent chain puromycylation. J Cell Biol. 2012;197(1):45–57. doi: 10.1083/jcb.201112145 22472439; PubMed Central PMCID: PMCPMC3317795.
54. Paul FE, Hosp F, Selbach M, Analyzing protein-protein interactions by quantitative mass spectrometry. Methods. 2011;54(4):387–95. doi: 10.1016/j.ymeth.2011.03.001 21382495.
55. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A, Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J. 2010;29(11):1851–64. doi: 10.1038/emboj.2010.77 20436455; PubMed Central PMCID: PMCPMC2885933.
56. Diem MD, Chan CC, Younis I, Dreyfuss G, PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs. Nat Struct Mol Biol. 2007;14(12):1173–9. doi: 10.1038/nsmb1321 18026120.
57. Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262 11846609.
58. Nishimura M, Watanabe T, Yagi S, Yamanaka T, Fujimuro M, Kaposi's sarcoma-associated herpesvirus ORF34 is essential for late gene expression and virus production. Sci Rep. 2017;7(1):329. doi: 10.1038/s41598-017-00401-7 28336944; PubMed Central PMCID: PMCPMC5428543.